戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              Genital herpes simplex is one of the most prevalent sexu
2                     Visits to physicians for genital herpes simplex virus (HSV) infection continue to
3                                  Importance: Genital herpes simplex virus (HSV) infection is a preval
4                                      Primary genital herpes simplex virus (HSV) infection is commonly
5                                              Genital herpes simplex virus (HSV) reactivation is thoug
6 he efficacy of valacyclovir and acyclovir on genital herpes simplex virus (HSV) shedding was assessed
7 n 500 million people are estimated to have a genital herpes simplex virus (HSV-2) infection.
8     Attempts to develop a vaccine to prevent genital herpes simplex virus 2 (HSV-2) disease have been
9                 Patients with newly acquired genital herpes simplex virus 2 (HSV-2) infection have vi
10 e epidemiological studies have reported that genital herpes simplex virus 2 (HSV-2) infection increas
11  study assessed 79 men (63 with a history of genital herpes simplex virus [HSV] type 2 infection, 5 w
12                                              Genital herpes simplex virus infections are widespread t
13 wice daily) for the suppression of recurrent genital herpes simplex virus infections in human immunod
14                                    Following genital herpes simplex virus type 2 (HSV-2) exposure, NK
15 icient (CXCL10(-/-)) mice which succumbed to genital herpes simplex virus type 2 (HSV-2) infection an
16                                              Genital herpes simplex virus type 2 (HSV-2) infection ca
17 min) relative to host immune defense against genital herpes simplex virus type 2 (HSV-2) infection ha
18  investigated the mechanism of resistance to genital herpes simplex virus type 2 (HSV-2) infection in
19     Clinical and virologic manifestations of genital herpes simplex virus type 2 (HSV-2) infection va
20 e vaccines are effective in animal models of genital herpes simplex virus type 2 (HSV-2) infection.
21 n = 188) from 29 patients with first-episode genital herpes simplex virus type 2 (HSV-2) infections w
22                   Effective vaccines against genital herpes simplex virus type 2 (HSV-2) may need to
23                      Using a mouse model for genital herpes simplex virus type 2 infection, we find t
24                     The clinical severity of genital herpes simplex virus-2 (HSV-2) infection varies
25                          In a mouse model of genital herpes simplex virus-2 (HSV-2) infection, which